[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14) [3078]
[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14)
| SMILES |
CC(C)C[C@@H](CN[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1Cc2c([nH]c3ccccc23)CN1)C(C)C |
| InChIKey |
IUYCRRDHLJIJBB-QAGBKCHLSA-N |
| Sequence |
XQWAVGHLL |
Chemical Properties
| Hydrogen bond acceptors |
12 |
| Hydrogen bond donors |
14 |
| Rotatable bonds |
30 |
| Log P |
0.374 |
| Molecular weight (Da) |
1105.6 |
| Stereochemistry info |
partial |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.